MAPBRILY Trademark

Trademark Overview


On Tuesday, April 23, 2024, a trademark application was filed for MAPBRILY with the United States Patent and Trademark Office. The USPTO has given the MAPBRILY trademark a serial number of 98515008. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, November 11, 2024. This trademark is owned by Celgene Corporation. The MAPBRILY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for human use.
mapbrily

General Information


Serial Number98515008
Word MarkMAPBRILY
Filing DateTuesday, April 23, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, November 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations for human use.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 23, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543

Trademark Events


Event DateEvent Description
Tuesday, April 23, 2024NEW APPLICATION ENTERED
Friday, October 11, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 6, 2024ASSIGNED TO EXAMINER
Monday, November 11, 2024NON-FINAL ACTION E-MAILED
Monday, November 11, 2024NON-FINAL ACTION WRITTEN
Monday, November 11, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED